[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Equine COVID-19 Antiserum [F(ab)2] (BSVEQAb)Along with Standard of care.: Dose of BSVEQAb - 5 mg/kg or 10 mg/kg body weight. It is administered as a single dose intravenously after diluting in 100 -150 ml saline. The infusion will be done over 1 to 2 hours. Standard of care for treatment of COVID-19 positive patientsControl Intervention1: Standard of Care: Treatment as per current treatment guidelines and institutes practice for COVID-19 positive patients will be administered", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Equine COVID-19 Antiserum [F(ab)2] (BSVEQAb)Along with Standard of care.: Dose of BSVEQAb - 5 mg/kg or 10 mg/kg body weight. It is administered as a single dose intravenously after diluting in 100 -150 ml saline. The infusion will be done over 1 to 2 hours. Standard of care for treatment of COVID-19 positive patients", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: Treatment as per current treatment guidelines and institutes practice for COVID-19 positive patients will be administered", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "5 mg/kg or 10 mg/kg body weight. It is administered as a single dose intravenously after diluting in 100 -150 ml saline", "treatment_id": 1152, "treatment_name": "Sars-cov-2 equine antiserum immunoglobulin (purified f(ab)2 fragment)", "treatment_type": "Immunoglobulins sars-cov-2 specific", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Equine COVID-19 Antiserum [F(ab)2] (BSVEQAb)Along with Standard of care.: Dose of BSVEQAb - 5 mg/kg or 10 mg/kg body weight. It is administered as a single dose intravenously after diluting in 100 -150 ml saline. The infusion will be done over 1 to 2 hours. Standard of care for treatment of COVID-19 positive patientsControl Intervention1: Standard of Care: Treatment as per current treatment guidelines and institutes practice for COVID-19 positive patients will be administered", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Equine COVID-19 Antiserum [F(ab)2] (BSVEQAb)Along with Standard of care.: Dose of BSVEQAb - 5 mg/kg or 10 mg/kg body weight. It is administered as a single dose intravenously after diluting in 100 -150 ml saline. The infusion will be done over 1 to 2 hours. Standard of care for treatment of COVID-19 positive patients", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: Treatment as per current treatment guidelines and institutes practice for COVID-19 positive patients will be administered", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]